Breaking News Instant updates and real-time market news.

CSII

Cardiovascular Systems

$30.59

-0.35 (-1.13%)

11:39
08/10/17
08/10
11:39
08/10/17
11:39

Cardiovascular Systems: Liberty study shows lasting benefits from PVI

Cardiovascular Systems released one-year data from its LIBERTY 360 degrees clinical study in a late-breaking presentation at the 2017 Amputation Prevention Symposium in Chicago. The LIBERTY 360 degrees study is designed to evaluate the acute and long-term clinical and economic outcomes of peripheral vascular interventions in patients with peripheral artery disease, PAD. With over 1,200 patients enrolled at 51 sites across the United States, it is among the first PAD studies to investigate patients across the spectrum of symptomatic PAD. As an "all comers" study, LIBERTY 360 degrees 's novel trial design included any endovascular device FDA-approved for treatment of PAD. One-year study outcomes were presented at AMP by Dr. Jihad Mustapha, Director of Cardiac Research at Metro Health Hospital, University of Michigan Health, Wyoming, Michigan. Dr. Mustapha's presentation highlighted results in the most severe form of PAD, called critical limb ischemia, that spans RC 4-6 and where amputation prevention should be the primary goal in treating these patients. 12-month data* from LIBERTY 360 degrees showed 96% freedom from amputation in RC 4-5 and 81.7% in RC 6. In addition, CLI patients in the study showed notable improvements in Rutherford Classification, Wound Healing, and Quality of Life out to 12 months.

CSII Cardiovascular Systems
$30.59

-0.35 (-1.13%)

06/21/17
BOFA
06/21/17
DOWNGRADE
BOFA
Underperform
Cardiovascular Systems downgraded to Underperform from Neutral at BofA/Merrill
05/04/17
LEER
05/04/17
NO CHANGE
Target $39
LEER
Outperform
Cardiovascular Systems price target raised to $39 from $30 at Leerink
Leerink analyst Danielle Antalffy raised her price target for Cardiovascular Systems to $39 from $30 after the company reported Q3 sales above the high end of management's guidance range and ahead of consensus. The analyst continues to believe Cardiovascular Systems' profitability is underappreciated by the Street. She reiterates an Outperform rating on the shares.
01/30/17
LSCM
01/30/17
INITIATION
Target $40
LSCM
Buy
Cardiovascular Systems initiated with a Buy at Lake Street
Lake Street analyst Brooks O'Neil started Cardiovascular Systems with a Buy rating and $40 price target. The company's leadership position in the peripheral and coronary vascular markets should drive "strong" revenue and profit growth over the next few quarters, O'Neil tells investors in a research note.
01/26/17
LEER
01/26/17
NO CHANGE
Target $30
LEER
Outperform
Cardiovascular Systems poised for growth momentum long-term, says Leerink
Leerink analyst Danielle Antalffy notes that Cardiovascular Systems reported Q2 sales at the high end of management's guidance range and ahead of consensus. The analyst recommends buying on weakness, as she believes Cardiovascular Systems represents a sustainable mid-to-high teens growth story for the next few years, with a faster track to profitability than originally expected. Antalffy reiterates an Outperform rating and $30 price target on the shares.

TODAY'S FREE FLY STORIES

CLS

Celestica

$11.55

-0.035 (-0.30%)

13:17
08/17/17
08/17
13:17
08/17/17
13:17
Upgrade
Celestica rating change  »

Follow-up: Celestica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

, AZN

AstraZeneca

$29.12

-0.0637 (-0.22%)

13:17
08/17/17
08/17
13:17
08/17/17
13:17
Hot Stocks
Breaking Hot Stocks news story on Tesaro, AstraZeneca »

Tesaro drops 2% after FDA…

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

AZN

AstraZeneca

$29.12

-0.0637 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

$NSD

NASDAQ Market Internals

13:17
08/17/17
08/17
13:17
08/17/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$29.11

-0.07 (-0.24%)

13:16
08/17/17
08/17
13:16
08/17/17
13:16
Hot Stocks
FDA posts approval of new dosage form for AstraZeneca's Lynparza 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

  • 08

    Sep

$NYE

NYSE Market Internals

13:16
08/17/17
08/17
13:16
08/17/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$19.72

-1.17 (-5.60%)

, LVLT

Level 3

$53.45

-1.73 (-3.14%)

13:13
08/17/17
08/17
13:13
08/17/17
13:13
Hot Stocks
CenturyLink says working to finalize Level 3 deal by end of Q3 »

CenturyLink (CTL) said in…

CTL

CenturyLink

$19.72

-1.17 (-5.60%)

LVLT

Level 3

$53.45

-1.73 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$19.73

-1.16 (-5.55%)

, LVLT

Level 3

$53.45

-1.73 (-3.14%)

13:12
08/17/17
08/17
13:12
08/17/17
13:12
Hot Stocks
Breaking Hot Stocks news story on CenturyLink, Level 3 »

CenturyLink says working…

CTL

CenturyLink

$19.73

-1.16 (-5.55%)

LVLT

Level 3

$53.45

-1.73 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$111.10

-0.48 (-0.43%)

13:10
08/17/17
08/17
13:10
08/17/17
13:10
Options
ADP attracts put buyers as shares come under fire »

ADP attracts put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADOM

Adomani

$12.86

0.86 (7.17%)

, VLKAY

Volkswagen

$31.10

0.19 (0.61%)

13:06
08/17/17
08/17
13:06
08/17/17
13:06
Hot Stocks
Adomani sees $2.9B in settlement funds from Volkswagen »

Adomani (ADOM) announced…

ADOM

Adomani

$12.86

0.86 (7.17%)

VLKAY

Volkswagen

$31.10

0.19 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.89

-0.05 (-0.42%)

13:05
08/17/17
08/17
13:05
08/17/17
13:05
Options
Horizon Pharma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLS

Celestica

$11.50

-0.08 (-0.69%)

13:04
08/17/17
08/17
13:04
08/17/17
13:04
Upgrade
Celestica rating change  »

Celestica upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDVX

Medovex

$0.95

0.05 (5.56%)

12:55
08/17/17
08/17
12:55
08/17/17
12:55
Hot Stocks
Medovex names Charlie Farrahar as CFO »

Medovex reported it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$33.20

-0.16 (-0.48%)

12:53
08/17/17
08/17
12:53
08/17/17
12:53
Hot Stocks
FDA posts approval of Pfizer's biologic license qpplication for Besponsa 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 08

    Sep

  • 08

    Sep

  • 13

    Sep

NADL

North Atlantic Drilling

$1.44

-0.075 (-4.97%)

12:50
08/17/17
08/17
12:50
08/17/17
12:50
Options
Notable put spread in North Atlantic Drilling »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

12:45
08/17/17
08/17
12:45
08/17/17
12:45
General news
Breaking General news story  »

Dallas Federal Reserve…

HRB

H&R Block

$30.21

-0.53 (-1.72%)

12:40
08/17/17
08/17
12:40
08/17/17
12:40
Options
Higher option volume in H&R Block driven by call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 14

    Sep

EXPE

Expedia

$148.78

1.72 (1.17%)

12:35
08/17/17
08/17
12:35
08/17/17
12:35
Options
Expedia put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
08/17/17
08/17
12:35
08/17/17
12:35
General news
Treasury Option Action: call buying at the long-end »

Treasury Option Action:…

ADP

ADP

$111.10

-0.48 (-0.43%)

12:32
08/17/17
08/17
12:32
08/17/17
12:32
Hot Stocks
Chapman says making dollar going against Ackman feels as good as $10 »

Robert Chapman of Chapman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADP

ADP

$111.10

-0.48 (-0.43%)

12:31
08/17/17
08/17
12:31
08/17/17
12:31
Hot Stocks
Breaking Hot Stocks news story on ADP »

Pershing Square's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADP

ADP

$111.10

-0.48 (-0.43%)

12:28
08/17/17
08/17
12:28
08/17/17
12:28
Hot Stocks
Breaking Hot Stocks news story on ADP »

Robert Chapman discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

SPY

SPDR S&P 500 ETF Trust

$245.04

-1.9 (-0.77%)

, SPX

S&P 500

12:28
08/17/17
08/17
12:28
08/17/17
12:28
Technical Analysis
Technical View: S&P 500 hits lows of the day at midsession »

The S&P 500 (SPX) was…

SPY

SPDR S&P 500 ETF Trust

$245.04

-1.9 (-0.77%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$79.14

-1.84 (-2.27%)

, BABA

Alibaba

$166.91

7.4092 (4.65%)

12:25
08/17/17
08/17
12:25
08/17/17
12:25
General news
On The Fly: Top stock stories at midday »

Stocks opened in negative…

WMT

Wal-Mart

$79.14

-1.84 (-2.27%)

BABA

Alibaba

$166.91

7.4092 (4.65%)

AMZN

Amazon.com

$978.18

-4.56 (-0.46%)

AABA

Altaba

$60.65

0.66 (1.10%)

LB

L Brands

$35.15

-3.805 (-9.77%)

NTAP

NetApp

$42.41

0.44 (1.05%)

CSCO

Cisco

$32.34

0.25 (0.78%)

CTL

CenturyLink

$19.83

-1.06 (-5.07%)

LVLT

Level 3

$53.60

-1.58 (-2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 18

    Aug

  • 23

    Aug

  • 24

    Aug

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 16

    Nov

  • 20

    Feb

HST

Host Hotels

$18.33

0.095 (0.52%)

12:20
08/17/17
08/17
12:20
08/17/17
12:20
Options
Hefty call spread in Host Hotels as a position is adjusted »

Hefty call spread in Host…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$35.35

-0.4 (-1.12%)

12:19
08/17/17
08/17
12:19
08/17/17
12:19
Periodicals
GM creditor cancels settlement with ignition switch plaintiffs, Reuters says »

A trust that holds many…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.